Marco Siccardi

4.7k citations
147 papers · 3.5k indexed · h-index 35

Marco Siccardi

145 papers receiving 3.5k citations

Peers

Marco Siccardi
Comparison fields: 5 of 139
  • Virology 954
  • Infectious Diseases 1.9k
  • Pharmaceutical Science 340
  • Pharmacology 321
  • Hepatology 289
Replace Laurent A. Décosterd with:
Laurent A. Décosterd Switzerland
Thomas Marbury United States
Catia Marzolini Switzerland
Kenneth C. Cundy United States
G. Richard Granneman United States
Chantal Csajka Switzerland
Bruno Lacarelle France
Peter J. Smith South Africa
Lane R. Bushman United States
Richard M. W. Hoetelmans Netherlands
Marco Siccardi relative to Laurent A. Décosterd Switzerland Laurent A. Décosterd's profile →
Citations per field
00.5×4.0×
Laurent A. Décosterd · 1×
Citations per year

Countries citing papers authored by Marco Siccardi

Since Specialization
Citations

This map shows the geographic impact of Marco Siccardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Siccardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Siccardi more than expected).

Fields of papers citing papers by Marco Siccardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Siccardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Siccardi. The network helps show where Marco Siccardi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Marco Siccardi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marco Siccardi Line = papers co-authored together Marco Siccardi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20244
2 202411
3 20235
4 20236
5 20235
6 20226
7 20226
8 202154
9 201649
10 201513
11 201513
12 20144
13 201420
14 20142
15 201342
16 201325
17 201221
18 201234
19 201128
20 201120

About Marco Siccardi

Marco Siccardi is a scholar working on Virology, Infectious Diseases and Pharmaceutical Science, having authored 147 papers that have together received 3.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (93 papers), HIV Research and Treatment (41 papers), Pharmacological Effects and Toxicity Studies (39 papers), HIV/AIDS Research and Interventions (25 papers), Drug Transport and Resistance Mechanisms (22 papers), Hepatitis C virus research (15 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Advanced Drug Delivery Systems (13 papers). The work is most often cited by research in Virology (954 citations), Infectious Diseases (1.9k citations) and Pharmaceutical Science (340 citations). Marco Siccardi has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Andrew Owen, Antonio D’Avolio, Giovanni Di Perri, David Back, Lorena Baietto, Stefano Bonora, Mauro Sciandra, Darren Moss, Saye Khoo and Marco Simiele. Their work appears in journals such as Nature Communications, Advanced Drug Delivery Reviews and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026